Forgive the new thread but it might be time to have a dedicated place for those Analyst snapshots that members post and are generally quite informative, but also Finance and even News media relating to Neuren's progress and prospects. The aim is to have a collation rather than scanning multiple threads as pieces get placed here or there.
Here's one, it might have been posted elsewhere:
https://unauthorised investment advice/health/neurens-stock-price-doubles-on-groundbreaking-drug-trial-ceo-says-its-just-getting-started/
Neuren Media and Analyst Coverage
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.35 |
Change
0.000(0.00%) |
Mkt cap ! $1.834B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 35 | $14.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.63 | 45 | 2 |
View Market Depth
| Last trade - 09.45am 27/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |
Day chart unavailable